In addition to other discoveries, the authors found that reported rates of myocarditis or pericarditis were higher after vaccination with mRNA-1273 (Moderna Spikevax) compared with BNT162b2 (Pfizer-BioNTech Comirnaty).
Peer-influenced content. Sources you trust. No registration required. This is HCN.
In addition to other discoveries, the authors found that reported rates of myocarditis or pericarditis were higher after vaccination with mRNA-1273 (Moderna Spikevax) compared with BNT162b2 (Pfizer-BioNTech Comirnaty).